Gastrointestinal Devices Market Size, Share, By Device Type (Gi Videoscopes, Biopsy Devices, Endoscopic Retrograde Cholangiopancreatography Devices [ERCP], Capsule Endoscopy, Endoscopic Ultrasound, and Others), Disease Type (Gastroesophageal Reflux Disease, Irritable Bowel Syndrome [IBS], Inflammatory Bowel Disease [IBD], Gastrointestinal Cancers, and Others), End-user (Hospitals, Specialized Clinics, Ambulatory Surgical Centers, and Others), and Region - Trends, Analysis, and Forecast till 2035

• By 2035, the target market is expected to increase at a rate of USD 22.7 Billion.
• The gastrointestinal devices market size was valued at USD 11.1 Billion in 2024.
• The market is mounting at a CAGR of 7.5%.

Gastrointestinal devices are the tools used to diagnose and treat conditions related to gastrointestinal (GI) system, which includes the stomach, intestines, liver, pancreas, and other digestive organs. These devices can help to functions, including monitoring, therapy, or assisting with surgical procedures in the GI tract. GI devices market include, endoscopy, capsule endoscopy, ERCP, biopsies and others, which used to examine, diagnose, and treat GI diseases. The increasing prevalence of GI disorders and advancements in minimally invasive technologies, drive the target market. The integration of AI and machine learning, which provides real-time analysis and early identification of conditions, such as colorectal cancer, resulting to drive GI devices market growth.

Impact of AI on Gastrointestinal Devices Market:

Artificial intelligence (AI) enhances polyp detection by improving the accuracy and efficiency of colonoscopies. AI can potentially reduce the need of unnecessary biopsies, which improves patient outcomes and streamlining endoscopic procedures. AI tools are used to automate screening process, such as identifying signs of inflammatory bowel disease (IBD), esophageal cancer, or other GI disorders from scanned images, and helping clinicians make quicker decisions. The AI in endoscopy market is growing rapidly, due to increasing adoption of AI-powered devices and software.

Key Drivers of Target Market:

Increasing Prevalence of Gastrointestinal Diseases is Anticipated to Increase the Market Growth

The growing prevalence of GI diseases, rises the demand for diagnostic tools, treatment devices, and monitoring solutions to manage these conditions. Changing lifestyle, such as poor diet, stress, alcohol consumption, contributes to rise in functional GI disorders, which require symptom management devices or digestive health supplements. Rise in gastrointestinal disorders, such as colon & rectum cancer, fatty liver disease, and GERD, increases demand for bariatric surgery devices, used in weight-loss surgeries and diagnostic tools to monitor complications arising from obesity-related GI conditions, leading to drive GI devices market growth.

• For instance, according to data published by American cancer society, in 2023, approximately 153,020 individuals was diagnosed with colon & rectum cancer (CRC) and 52,550 die from the disease, including 19,550 cases and 3,750 deaths in individuals younger than 50 years of age. There will be 46,050 new cases of rectal cancer, which is more common in younger people. The risk of colorectal cancer is higher in men than in women, the number of new cases in people ages 65 years and older is similar because of higher life expectancy in women.

Restraints:

Lack of Skilled Professionals and High Cost of Advanced GI Devices Disrupt Target Market Growth

GI devices require skilled professionals to operate imaging techniques correctly and make informed decisions during surgery. Devices, such as robotic systems, AI-powered diagnostic tools, and minimally invasive surgical instrument often require high initial setup cost. This can be barrier for healthcare institutions, and smaller healthcare settings for managing maintenance and training requirements for these advanced systems, leads to disrupt the target market growth.

• Counterbalance Statements: The rise of training programs, and certifications for advanced GI devices to help educate healthcare professionals with advanced technologies. Remote training, telemedicine, and AI-assisted guidance help to real-time support and insights. Smaller healthcare settings should collaborate with pharmaceutical companies to implant advanced technologies.

Opportunities & Market Trends:

Improvement in Artificial Intelligence and Machine Learning Integration in GI Devices Boosts Market Opportunity

The integration of artificial intelligence (AI) and machine learning (ML) in GI devices enhance the functionality of devices by providing real-time image interpretation, anatomy detection and predictive analytics. AI can significantly analyze medical images, guide surgical instruments and provide instant result to surgeons. AI and ML algorithms can analyze vast amounts of data from endoscopic images, biopsy results, and patient records more quickly and accurately than human clinicians. These technologies are improving the ability to detect early-stage gastrointestinal diseases, such as pancreatic cancer, colorectal cancer, inflammatory bowel disease (IBD), and esophageal cancer.

• For instance, according to article published by Mayo Foundation for Medical Education and Research (MFMER) in January 2025, this article highlights that the development of  natural language processing algorithms that identify familial and genetic risk of pancreatic cancer from unstructured clinical notes within the EHR. AI and ML based models are used to transform health data summarization and visualization capabilities. AI and ML capabilities to develop EHR-based applications that accurately identify known and novel risk factors for pancreatic cancer.

The gastrointestinal devices is distributed into device type, disease type, end-user, and region.

Device Type:

Based on device type, gastrointestinal devices market is categorized into, Gi videoscopes, biopsy devices, endoscopic retrograde cholangiopancreatography devices (ERCP), capsule endoscopy, endoscopic ultrasound, and others. Gi videoscopes segment dominates in target market. Gi videoscopes includes, flexible endoscopes used in gastroscopy, colonoscopy and enterostomy for diagnosing and treating GI diseases. As the prevalence of GI diseases, particularly colorectal cancer and IBD, rises, the demand for advanced video quality, portability and AI integration for effective and accessible treatment, is anticipated to drive DI devices market size.

• For instance, in October2023, Olympus Corporation, launched next-generation EVIS X1 endoscopy system in the U.S. The new technologies aimed to visualizing the GI tract, which are designed to help physicians. The new EVIS X1 endoscopy system, along with two compatible gastrointestinal endoscopes, known as GIF-1100 gastrointestinal videoscope, and CF-HQ1100DL/I colonovideoscope. The GIF-1100 gastrointestinal videoscope used within the upper digestive tract and the CF-HQ1100DL/I colonovideoscope used within the lower digestive tract, including the anus, rectum, sigmoid colon, colon and ileocecal valve.

Disease Type:

Gastroesophageal reflux disease, irritable bowel syndrome [IBS], inflammatory bowel disease [IBD], and others, are the divided by disease type for gastrointestinal devices market.  Gastroesophageal reflux disease (GERD) hold the largest share in target market, due to high prevalence of GI chronic diseases, and changing lifestyle, such as poor diet, smoking, and high alcohol consumption contribute to the condition. The demand for diagnostic tools such as, endoscopes, pH monitoring systems, and biopsy devices, leading to growth of GI devices market share.

• For instance, the data published by National Health of Medicine, in 2023, GERD is one of the most common gastrointestinal disorders, with a prevalence of approximately 20% of adults in western culture, in the U.S. between 18.1% to 27.8%. The prevalence of GERD is slightly higher in men as compared to women. Women with GERD symptoms have a higher incidence of erosive esophagitis then men. However, men with symptoms of GERD have a higher incidence of Barrett's esophagus (23%) compared to women.

End-user:

By end-user, the gastrointestinal devices is segmented into hospitals, specialized clinics, ambulatory surgical centers and others. The hospitals segment play dominates role target market, as hospitals contains advanced gastrointestinal devices that help surgeon for safe performance & less procedures and it gives standard protocol for managing disorders. The growing demand for clinical workflows for the cost-effective optimization, resulting to drive gastrointestinal devices market growth. 

 Region:

Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America: North America hold the largest share in target market, due to the high rate of adoption of new technologies and availability of skilled healthcare professionals to perform technically advanced surgeries. Increasing healthcare infrastructure and presence of major key players, anticipated to growth of GI devices market share.

• For instance, April 2023, American Gastroenterological Association's (AGA) invested in EvoEndo to support innovative technology that has potential to improve care, save time and cost for hospitals. The EvoEndo Single-Use Endoscopy System received FDA clearance which includes a sterile, single-use, flexible gastroscope designed for transnasal upper endoscopy and a small portable video controller. This system was aimed to design for the visualization of the upper digestive trat in adults and pediatric patients for the observation, diagnosis and endoscopic treatment of stomach in patients.

Asia Pacific: Asia Pacific is fastest growing region for target market, due to boosting demand for advanced GI devices to diagnose, treat, and monitor GI diseases. The government initiative to support the growth of healthcare industry and rising funding for healthcare infrastructure, anticipated to growth of gastrointestinal devices market in few years.

Gastrointestinal Devices Report Scope:

Segmentation:

By Device Type:

• Gi Videoscopes
• Biopsy Devices
• Endoscopic Retrograde Cholangiopancreatography Devices (ERCP)
• Capsule Endoscopy
• Endoscopic Ultrasound
• Others

By Disease Type:

• Gastroesophageal Reflux Disease
• Irritable Bowel Syndrome [IBS]
• Inflammatory Bowel Disease [IBD]
• Gastrointestinal Cancers
• Others

By End-user:

• Hospitals
• Specialized Clinics
• Ambulatory Surgical Centres
• Others

By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Indonesia
  • Malaysia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating in the Gastrointestinal Devices include Boston Scientific Corporation, FUJIFILM Corporation, Karl Storz GmbH & Co. Kg, and others. Major companies are developing strategies, making collaboration and partnerships with other companies to develop advanced techniques, and introducing more effective technology in urology healthcare, resulting to drive GI devices market in upcoming years.

Gastrointestinal Devices Market Companies:

• CONMED Corporation
• Boston Scientific Corporation
• FUJIFILM Corporation
• Karl Storz GmbH & Co. KG
• Siemens
• Olympus Corporation
• Medtronic
• Stryker
• Cook
• MICRO-TECH (Nanjing) Co., Ltd
• B. Braun SE
• Johnson & Johnson Services, Inc.
• PENTAX Medical
• Richard Wolf GmbH
• STERIS

View a Additional List of Companies in Gastrointestinal Devices Market

• In April 2024, Medtronic plc, introduced a ColonPRO software for the GI Genius intelligent endoscopy system. The GI Genius system was the first commercially available computer-aided detection (CADe) system that uses AI to identify colorectal polyps. The ColonPRO software update introduces a new feature that provides procedural highlights during endoscopic procedures. These AI-driven GI devices aimed to reduce false positives, and enhanced workflow automation, with early detection of colorectal polyps to enhance better patient care.
• In February 2024, FUJIFIM India launched advanced endoscopic ultrasound machine, known as ALOKA ARIRTTA 850 in Bengaluru, Karnataka. It was aimed to enhance diagnostic services and detection of pancreatic cancers.  This new system represents advancement in endoscopic technologies, with high-tech ultrasound system aimed to enhance diagnostic precision and image clarity for gastrointestinal diseases.

Analyst View:

Gastrointestinal devices market is set to substantial growth due to rising prevalence of Gi diseases such as, GERD, IBD, colorectal cancer, pancreatic cancer, and growing adoption of AI and robotic technology in endoscopic procedures, is anticipated to growth of GI devices market. High-growth in emerging economics, and early detection of GI cancer, is projected to growth of GI devices market share in upcoming years.

More Related Reports

Implantable Drug Device Market
Diabetes Monitoring Device Market
Personal Mobility Devices Market
Biopsy Devices Market
Endoscopic Spinal Surgery Market